Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285

Literals

bibo:volume
- 168
bibo:doi
- 10.1016/j.ijcard.2013.04.097
dcterms:creator
- Stathopoulou M.G.
dcterms:contributor
- Stathopoulou M.G.; Monteiro P.; Shahabi P.; Penas-Lledo E.; El Shamieh S.; Silva Santos L.; Thilly N.; Siest G.; Llerena A.; Visvikis-Siest S.
ou:vecesCitado
- 4
ou:eid
- 2-s2.0-84885663886
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84885663886&origin=inward
ou:tipoPublicacion
- Article
vivo:identifier
- 2013-299
bibo:eissn
- 1874-1754
bibo:issn
- 0167-5273
dcterms:publisher
- International Journal of Cardiology
bibo:page_range
- 3057-3058
fabio:hasPublicationYear
- 2013
dcterms:title
- Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84885663886&origin=inward
ou:urlOrcid
- http://europepmc.org/abstract/med/23643422